526
Participants
Start Date
August 31, 2008
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
GSK1838262
Flexible dosing: 1200 mg/day, 1800 mg/day, 2400 mg/day and 3000 mg/day
Placebo
Placebo-control
GSK Investigational Site, Albany
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Philadelphia
GSK Investigational Site, Philadelphia
GSK Investigational Site, Alexandria
GSK Investigational Site, Greensboro
GSK Investigational Site, Raleigh
GSK Investigational Site, Raleigh
GSK Investigational Site, Charleston
GSK Investigational Site, Stockbridge
GSK Investigational Site, Atlanta
GSK Investigational Site, DeLand
GSK Investigational Site, Sunrise
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Birmingham
GSK Investigational Site, Nashville
GSK Investigational Site, Memphis
GSK Investigational Site, Westerville
GSK Investigational Site, Cleveland
GSK Investigational Site, West Chester
GSK Investigational Site, Kalamazoo
GSK Investigational Site, Golden Valley
GSK Investigational Site, Chicago
GSK Investigational Site, St Louis
GSK Investigational Site, Kansas City
GSK Investigational Site, Springfield
GSK Investigational Site, Wichita
GSK Investigational Site, Houston
GSK Investigational Site, San Antonio
GSK Investigational Site, Denver
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Las Vegas
GSK Investigational Site, Santa Monica
GSK Investigational Site, Westlake Village
GSK Investigational Site, Redlands
GSK Investigational Site, Newport Beach
GSK Investigational Site, Anaheim
GSK Investigational Site, San Francisco
GSK Investigational Site, Seattle
GSK Investigational Site, Wenatchee
GSK Investigational Site, Penticton
GSK Investigational Site, Surrey
GSK Investigational Site, Bay Roberts
GSK Investigational Site, Brampton
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Ottawa
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Saint Romuald
GSK Investigational Site, Sherbrooke
Collaborators (1)
GlaxoSmithKline
INDUSTRY
XenoPort, Inc.
INDUSTRY